First tube station to get Wi-Fi next week • The Register

Charing Cross will become the first London Underground station to offer wireless internet access from next week.

BT Openzone will run a six-month trial in the ticket hall area and on Northern and Bakerloo line platforms. There won’t be any access on trains.

The service will be offered on the same basis as other BT Openzone hotspots: free to BT broadband subscribers and Fon members, and available for a fee to others.

BBC offers to pay for World Service to avoid licence fee raid | Media |

The BBC director general, Mark Thompson, is prepared to meet some or all of the £300m annual costs of running the World Service, in a last-ditch attempt to prevent a £556m raid on its finances to fund the cost of free TV licences for the over-75s, can reveal.

Brilliant: Charlie Brooker | How to save the economy without really trying: a guide for Gideon Osborne

Just a quote to tease you into reading the full article:

The coalition has repeatedly promised that those with the broadest shoulders will bear the greatest load; unfortunately, the majority of people develop broad shoulders by doing underpaid manual work, not trading stocks from the comfort of a Herman Miller Aeron chair. (Or writing for publication: I have the upper-body-strength of a nine-year-old girl.)

Google prepara un indicador de la inflación en la red – BBC Mundo

Los caminos de Google hace ya tiempo que son inescrutables. Pocos días después de desvelarse que preparan un auto que se maneja solo, ahora se sabe que también se ha lanzado a construir su índice de precios, su propia vara para medir la inflación en internet.

Basado en la vasta información sobre precios en la red, la compañía californiana trabaja en la construcción del Índice de Precios de Google (Google Price Index, en inglés), que en el futuro podría devenir en referencia alternativa a los balances oficiales.

First human trial of embryonic stem cells – BBC News

US doctors have begun the first official trial of using human embryonic stem cells in patients after getting the green light from regulators.

The Food and Drug Administration has given a license to Geron to use the controversial cells to treat people with spinal injuries.

The cells have the potential to become many of the different cell types found in the body, including nerve cells.

The trials at a hospital in Atlanta will check if the treatment is safe.